PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21533229-6	2011	At the peak response time point, PBMC from Ad5-seronegative vaccinees secreted significantly more IP-10 in response to Gag (p = 0.008), and significantly more IP-10 (p = 0.0009), IL-2 (p = 0.006) and IL-10 (p = 0.05) in response to Ad5 empty vector than PBMC from Ad5-seropositive vaccinees.	Glycosaminoglycans	119-122	Alzheimer disease, familial, type 5	Homo sapiens	43-46	
21533229-8	2011	The cytokine response profile of Gag-specific T cells mirrored the Ad5-specific response present in all subjects before vaccination, and included a number of Th1- and Th2-associated cytokines not routinely assessed in current vaccine trials, such as IP-10, IL-10, IL-13, and GM-CSF.	Glycosaminoglycans	33-36	Alzheimer disease, familial, type 5	Homo sapiens	67-70	
21533229-5	2011	The overall profiles of cytokine responses to Gag and Ad5 had similar combinations of induced Th1- and Th2-type cytokines, including IFN-gamma, IL-2, TNF-alpha, IP-10, IL-13, and IL-10, although the Ad5-specific responses were uniformly higher than the Gag-specific responses (p<0.0001 for 9 out of 11 significantly expressed analytes).	Glycosaminoglycans	46-49	Alzheimer disease, familial, type 5	Homo sapiens	199-202	
10704346-4	2000	The HS-GAG analog heparin decreased Ad5- and Ad2-mediated infection and binding starting from the concentration of 0.1 microgram/ml, up to a maximum of 50%.	Glycosaminoglycans	7-10	Alzheimer disease, familial, type 5	Homo sapiens	36-39